Cargando…

Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report

INTRODUCTION AND IMPORTANCE: Nivolumab, which is a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, has been recommended as a third-line treatment based on the results of the ATTRACTION-2 study involving patients with unresectable advanced gastric cancer. CASE PRESENTATION: A 69 year-old...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komo, Toshiaki, Suzuki, Takahisa, Tazawa, Hirofumi, Sada, Haruki, Morimoto, Hiroshi, Shimada, Norimitsu, Hadano, Naoto, Onoe, Takashi, Sudo, Takeshi, Shimizu, Yosuke, Tashiro, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264597/ https://www.ncbi.nlm.nih.gov/pubmed/34237686 http://dx.doi.org/10.1016/j.ijscr.2021.106161

Ejemplares similares

A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab
por: Tazawa, Hirofumi, et al.
Publicado: (2019)

Laparoscopic resection for a large gastrointestinal stromal tumor (GIST) with diaphragm invasion following preoperative imatinib treatment: A case report
por: Yoshioka, Shoko, et al.
Publicado: (2021)

Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
por: Tazawa, Hirofumi, et al.
Publicado: (2021)

Gastric adenocarcinoma appearance in leiomyoma: A case report
por: Wada, Kaoru, et al.
Publicado: (2020)

Analysis of Acquisition of COVID-2019 Neutralizing Antibodies in Organ Transplant Recipients
por: Akimoto, Shuji, et al.
Publicado: (2023)

A case of Turcot’s syndrome type 1 with loss of immunoexpression of MSH6 in colon cancer and liver metastasis due to secondary somatic mutation in coding mononucleotide (C)8 tract: a case report
por: Akabane, Shintaro, et al.
Publicado: (2020)

Laproscopic treatment for small bowel bleeding after detection by double-balloon endoscopy: A case report
por: Akabane, Shintaro, et al.
Publicado: (2019)

Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report
por: Misumi, Toshihiro, et al.
Publicado: (2012)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Aneurysm of the inferior vena cava with thrombosis
por: Inoue, Masashi, et al.
Publicado: (2018)

Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer
por: Toyota, Satoshi, et al.
Publicado: (2020)

A case of hepatic pseudolymphoma in a patient with primary biliary cirrhosis
por: Inoue, Masashi, et al.
Publicado: (2019)

The new prognostic score for unresectable or recurrent gastric cancer treated with nivolumab: A multi‐institutional cohort study
por: Sato, Sho, et al.
Publicado: (2021)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
por: Kuo, Hsin-Yu, et al.
Publicado: (2022)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Miyamoto, Yosuke, et al.
Publicado: (2021)

Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection
por: Fujimura, Taku, et al.
Publicado: (2019)

First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis
por: Yang, Liu, et al.
Publicado: (2023)

Reply to “The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia”
por: Ebara, Hirotaka, et al.
Publicado: (2017)

Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy
por: Sekido, Katsuhisa, et al.
Publicado: (2023)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma
por: Namikawa, Kenjiro, et al.
Publicado: (2020)

Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma
por: Ye, Zhuo-miao, et al.
Publicado: (2022)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Neural Substrates for the Motivational Regulation of Motor Recovery after Spinal-Cord Injury
por: Nishimura, Yukio, et al.
Publicado: (2011)

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma
por: Yang, Liu, et al.
Publicado: (2022)

Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer
por: Mimura, Kosaku, et al.
Publicado: (2023)

Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report
por: Shibata, Yosuke, et al.
Publicado: (2021)

Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report
por: Miyamoto, Reina, et al.
Publicado: (2020)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

Successful surgical management of non-perforating acute appendicitis with septic disseminated intravascular coagulation: A case report and review of the literature
por: Komo, Toshiaki, et al.
Publicado: (2019)

Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report
por: Takami, Tomoya, et al.
Publicado: (2021)

Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience
por: Kubota, Yohei, et al.
Publicado: (2022)

A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration
por: Yamaguchi, Takahisa, et al.
Publicado: (2021)

Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX
por: Shirasu, Hiromichi, et al.
Publicado: (2018)

Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report
por: Onoe, Takashi, et al.
Publicado: (2018)

A rare case of transient left ventricular apical ballooning syndrome following living donor liver transplantation: A case report and literature review
por: Tanaka, Asuka, et al.
Publicado: (2019)

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
por: Nordgård, Oddmund, et al.
Publicado: (2022)

Four cases of disseminated herpes simplex virus following talimogene laherparepvec injections for unresectable metastatic melanoma
por: Beekman, Kate E., et al.
Publicado: (2023)

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies
por: Rixe, Olivier, et al.
Publicado: (2015)

Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma
por: Ohsawa, Manato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_omsnmth0749tng0l0i8p4a6gl0